Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning

被引:0
|
作者
Valle, Leonardo Guedes Moreira [1 ]
Cunha, Marcela Juliano Silva [1 ]
Schmid, Bruno Pagnin [1 ]
Falsarella, Priscila Mina [1 ]
de Rezende, Marcelo Bruno [1 ]
Felga, Guilherme Eduardo Goncalves [1 ]
Ogawa, Renata Emy [1 ]
Garcia, Rodrigo Gobbo [1 ]
Affonso, Breno Boueri [1 ]
Nasser, Felipe [1 ]
Galastri, Francisco Leonardo [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2023年 / 21卷
关键词
Living donors; Liver neoplasms; Carcinoma; hepatocellular; Chemoembolization; therapeutic; Neoadjuvant therapy; Response evaluation criteria in solid tumors; Radiology; interventional; TRANSARTERIAL CHEMOEMBOLIZATION;
D O I
10.31744/einstein_journal/2023AO0307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the radiological characteristics of hepatocellular carcinoma (HCC) lesions that achieved a complete response following drug-eluting bead transarterial chemoembolization (DEB-TACE) preceding liver transplantation. Methods: This single-center case-control study enrolled patients with hepatocellular carcinoma who underwent neoadjuvant DEB-TACE therapy, were followed up with contrast-enhanced magnetic resonance imaging or computed tomography, and were successively evaluated according to the modified Response Evaluation Criteria in Solid Tumors. The HCCs were divided into two groups based on their diameter (Group A: <= 3cm; Group B: 3cm). Viability was assessed using the Kaplan-Meier method according to tumor size categories. The relationship between tumor variables was analyzed using bivariate Cox regression.Results: Three-hundred and twenty-eight patients with 667 hepatocellular carcinomas who underwent their first DEB-TACE session were enrolled. A total of 105 hepatocellular carcinomas in 59 patients exhibited complete response after the initial DEB-TACE session and were divided into Group A (92 HCCs) and Group B (13 HCCs). The diameter in Group A decreased significantly compared to the pre-procedure size until the second assessment (p<0.001), with no subsequent reduction in diameter, despite maintaining a complete response. In Group B, the reduction in diameter remained significant compared with the initial value until the sixth imaging evaluation (p=0.014). The average reduction was 45.1% for Group B and a maximum of 14.9% in Group A.Conclusion: HCCs >3cm exhibited a greater reduction in size and a longer time to recurrence. HCCs <= 3cm had a shorter relapse time. The recurrence rates were similar. These findings may aid in planning for liver transplantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Complete contrast staining of hepatocellular carcinoma during drug-eluting bead chemoembolization predicts a favorable response
    Alharbi, Sultan R.
    JOURNAL OF CLINICAL IMAGING SCIENCE, 2024, 14
  • [32] IMPACT OF DRUG-ELUTING BEAD CHEMOEMBOLIZATION ON SURVIVAL AND RECURRENCE OF HEPATOCELLULAR CARCINOMA (HCC) POST LIVER TRANSPLANTATION
    Rojas, Haydy
    Franco, Edson S.
    Davis, Cliff
    Zwiebel, Bruce
    Brantley, Stephen
    Neff, Guy
    Alsina, Angel
    HEPATOLOGY, 2011, 54 : 1416A - 1416A
  • [33] Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
    Hetta, Waleed M.
    Shebria, Naglaa
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2014, 45 (03): : 761 - 769
  • [34] Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
    Murata, Yosuke
    Hiramatsu, Katsushi
    Yoshida, Yumi
    Akazawa, Yu
    Saito, Yasushi
    Nosaka, Takuto
    Ozaki, Yoshihiko
    Hayama, Ryoko
    Takahashi, Kazuto
    Naito, Tatsushi
    Ofuji, Kazuya
    Matsuda, Hidetaka
    Ohtani, Masahiro
    Nemoto, Tomoyuki
    Nakamoto, Yasunari
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2019, 12 (01) : 76 - 81
  • [35] Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma
    Yosuke Murata
    Katsushi Hiramatsu
    Yumi Yoshida
    Yu Akazawa
    Yasushi Saito
    Takuto Nosaka
    Yoshihiko Ozaki
    Ryoko Hayama
    Kazuto Takahashi
    Tatsushi Naito
    Kazuya Ofuji
    Hidetaka Matsuda
    Masahiro Ohtani
    Tomoyuki Nemoto
    Yasunari Nakamoto
    Clinical Journal of Gastroenterology, 2019, 12 : 76 - 81
  • [36] Safety and Feasibility of Same-Day Discharge of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization with Drug-Eluting Beads in a Liver Transplantation Program
    Nasser, Felipe
    Cavalcante, Rafael N.
    Galastri, Francisco L.
    de Rezende, Marcelo B.
    Felga, Guilherme G.
    Travassos, Fabiellen B.
    De Fina, Bruna
    Affonso, Breno B.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (07) : 1012 - 1017
  • [37] Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
    Zhou, Guan-Hui
    Han, Jun
    Sun, Jun-Hui
    Zhang, Yue-Lin
    Zhou, Tan-Yang
    Nie, Chun-Hui
    Zhu, Tong-Yin
    Chen, Sheng-Qun
    Wang, Bao-Quan
    Yu, Zi-Niu
    Wang, Hong-Liang
    Chen, Li-Ming
    Wang, Wei-Lin
    Zheng, Shu-Sen
    BMC CANCER, 2018, 18
  • [38] Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
    Guan-Hui Zhou
    Jun Han
    Jun-Hui Sun
    Yue-Lin Zhang
    Tan-Yang Zhou
    Chun-Hui Nie
    Tong-Yin Zhu
    Sheng-Qun Chen
    Bao-Quan Wang
    Zi-Niu Yu
    Hong-Liang Wang
    Li-Ming Chen
    Wei-Lin Wang
    Shu-Sen Zheng
    BMC Cancer, 18
  • [39] Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size
    Lee, Yong Kang
    Jung, Kyu Sik
    Kim, Do Young
    Choi, Jin Young
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Gyoung Min
    Kim, Man Deuk
    Park, Sung Il
    Won, Jong Yun
    Lee, Do Yun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (02) : 487 - 496
  • [40] Survival Outcomes of Very Small Drug-Eluting Beads Used in Chemoembolization of Unresectable Hepatocellular Carcinoma
    Aal, Ahmed Kamel Abdel
    Moawad, Sherif
    Vande Lune, Patrick
    El Khudari, Husameddin
    Hanaoka, Mauro Mitusru
    Abouldahab, Noha
    Gunn, Andrew J.
    White, Jared
    Shoreibah, Mohamed
    Li, Yufeng
    Saddekni, Souheil
    Mahmoud, Khalid
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (09) : 1325 - 1334